EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 255 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,529 | -13.8% | 8,914 | -9.1% | 0.04% | -12.5% |
| Q2 2023 | $80,695 | +13.9% | 9,805 | +0.4% | 0.05% | +23.1% |
| Q1 2023 | $70,825 | -40.9% | 9,769 | -27.7% | 0.04% | -38.1% |
| Q4 2022 | $119,922 | -6.3% | 13,520 | +29.5% | 0.06% | +23.5% |
| Q3 2022 | $128,000 | +4.1% | 10,440 | +0.7% | 0.05% | +10.9% |
| Q2 2022 | $123,000 | +19.4% | 10,370 | +91.2% | 0.05% | 0.0% |
| Q1 2022 | $103,000 | -32.2% | 5,425 | -5.5% | 0.05% | -19.3% |
| Q4 2021 | $152,000 | -33.0% | 5,740 | +4.0% | 0.06% | -43.0% |
| Q3 2021 | $227,000 | -31.0% | 5,518 | -5.0% | 0.10% | -25.9% |
| Q2 2021 | $329,000 | +60.5% | 5,806 | +18.9% | 0.14% | +55.2% |
| Q1 2021 | $205,000 | -39.0% | 4,884 | +1.8% | 0.09% | -37.4% |
| Q4 2020 | $336,000 | +5.0% | 4,798 | -58.0% | 0.14% | -17.3% |
| Q3 2020 | $320,000 | -16.7% | 11,417 | -12.1% | 0.17% | -7.7% |
| Q2 2020 | $384,000 | – | 12,987 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deep Track Capital, LP | 7,101,935 | $55,395,093 | 2.14% |
| Green Alpha Advisors, LLC | 77,188 | $602,066 | 0.46% |
| Woodline Partners LP | 3,259,710 | $25,425,738 | 0.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $1,560,000 | 0.22% |
| Spectrum Planning & Advisory Services Inc. | 14,038 | $109,496 | 0.17% |
| PDT Partners, LLC | 156,515 | $1,220,817 | 0.15% |
| CALTON & ASSOCIATES, INC. | 13,420 | $104,676 | 0.15% |
| Corton Capital Inc. | 29,365 | $229,047 | 0.12% |
| CAXTON ASSOCIATES LP | 61,223 | $477,539 | 0.07% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 119,287 | $930,439 | 0.06% |